The diagnostic IDH1/2 NCN, white blood cell counts, hemoglobin, platelet counts, percentages of circulating or marrow blasts, and the mutation status of NPM1 had no effect on the correlation between IDH1/2 LNA-qPCR MRD and AML remission status (Table 3). This evidence concerns the gene NPM1 and acute myeloid leukemia.